truckcry34
About
Surufatinib within sophisticated pancreatic neuroendocrine tumours (SANET-p): a randomised, double-blind, placebo-controlled, stage 3 research.
Surufatinib within sophisticated pancreatic neuroendocrine tumours (SANET-p): a randomised, double-blind, placebo-controlled, stage 3 research.